Barclays’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$449K Buy
122,552
+32,403
+36% +$119K ﹤0.01% 3090
2025
Q1
$389K Sell
90,149
-20,766
-19% -$89.6K ﹤0.01% 2982
2024
Q4
$355K Buy
110,915
+16,106
+17% +$51.6K ﹤0.01% 3243
2024
Q3
$271K Buy
94,809
+67,855
+252% +$194K ﹤0.01% 3333
2024
Q2
$76K Sell
26,954
-22,306
-45% -$62.9K ﹤0.01% 3503
2024
Q1
$140K Sell
49,260
-46,942
-49% -$133K ﹤0.01% 3509
2023
Q4
$394K Buy
96,202
+70,926
+281% +$290K ﹤0.01% 3135
2023
Q3
$80K Buy
25,276
+11,284
+81% +$35.7K ﹤0.01% 3409
2023
Q2
$47K Sell
13,992
-88,836
-86% -$298K ﹤0.01% 3705
2023
Q1
$218K Sell
102,828
-3,963
-4% -$8.4K ﹤0.01% 3096
2022
Q4
$288K Buy
106,791
+67,203
+170% +$181K ﹤0.01% 2911
2022
Q3
$129K Buy
39,588
+19,548
+98% +$63.7K ﹤0.01% 3301
2022
Q2
$98K Sell
20,040
-32,041
-62% -$157K ﹤0.01% 3477
2022
Q1
$397K Sell
52,081
-6,582
-11% -$50.2K ﹤0.01% 2939
2021
Q4
$543K Buy
58,663
+9,766
+20% +$90.4K ﹤0.01% 2494
2021
Q3
$696K Buy
48,897
+11,311
+30% +$161K ﹤0.01% 2440
2021
Q2
$626K Buy
37,586
+14,941
+66% +$249K ﹤0.01% 2357
2021
Q1
$413K Buy
22,645
+9,503
+72% +$173K ﹤0.01% 2754
2020
Q4
$99K Sell
13,142
-1,458
-10% -$11K ﹤0.01% 2980
2020
Q3
$56K Sell
14,600
-1,847
-11% -$7.08K ﹤0.01% 3236
2020
Q2
$64K Buy
16,447
+7,151
+77% +$27.8K ﹤0.01% 3315
2020
Q1
$30K Sell
9,296
-7,028
-43% -$22.7K ﹤0.01% 3277
2019
Q4
$79K Buy
16,324
+11,130
+214% +$53.9K ﹤0.01% 3495
2019
Q3
$34K Sell
5,194
-1,597
-24% -$10.5K ﹤0.01% 3773
2019
Q2
$52K Sell
6,791
-4,038
-37% -$30.9K ﹤0.01% 3818
2019
Q1
$81K Buy
+10,829
New +$81K ﹤0.01% 3436